Durham Dales Health and GSK (COPD)
Durham Dales Health and GlaxoSmithKline are engaged in Joint Working to enhance the management of Chronic Obstructive Pulmonary Disease (COPD) to a standard of care defined by NICE (National Institute for Health and Clinical Excellence).
Both parties have committed resources to support this project, which will run from April 2011 to September 2012
The objective of this Joint Working project is to improve quality and productivity in the management of patients with COPD within the consortium.
It is designed to support:
- Improved quality of life for COPD patients
- The promotion of disease prevention and the earlier identification of patients with COPD through healthcare professional education.
- Accurate diagnosis and classification of disease with access to high quality information.
- Prevention of COPD exacerbations through increased patient review and appropriate use of medications in line with NICE guidance.
- Improving the quality of COPD referrals to secondary care and community teams.
- A reduced need for unscheduled care
- Equitable, cost effective service delivery across all practices in the consortium.
For further information please contact:
Alison Newbolt, Area Business Manager, GSK. Email: alison.j.newbolt@gsk.com
Kathryn Kemp, Integrated Healthcare Manager, GSK
Email: Kathryn.x.kemp@gsk.com
UK/PPM/0112/11 – April 2011